Illumina at JP Morgan 39th Healthcare Conference 2021

Illumina President & CEO Francis deSouza presents at the J.P. Morgan 39th Annual Healthcare Conference, discussing the company's role in pandemic response through sequencing technology, including vaccine development, PCR testing, and viral strain identification. The presentation addresses forward-looking business performance and the pending acquisition of GRAIL, Inc.